SBRA
Sabra Health Care REIT, Inc.
REIT - Healthcare Facilities
Market Cap$5.14B
5Y Perf.+51.4%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
SBRA vs WELL
Revenue, margins, valuation, and 5-year total return — side by side.
WELL
Welltower Inc.
REIT - Healthcare Facilities
Market Cap$150.14B
5Y Perf.+322.9%
SBRA vs WELL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | SBRA | WELL |
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $5.14B | $150.14B |
| Revenue (TTM) | $813M | $11.63B |
| Net Income (TTM) | $156M | $1.43B |
| Gross Margin | 63.5% | 39.1% |
| Operating Margin | 29.0% | 4.4% |
| Forward P/E | 29.5x | 78.9x |
| Total Debt | $2.55B | $21.38B |
| Cash & Equiv. | $72M | $5.03B |
SBRA vs WELL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
SBRA
WELL
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Sabra Health Care R… (SBRA) | 100 | 151.4 | +51.4% |
| Welltower Inc. (WELL) | 100 | 422.9 | +322.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBRA vs WELL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: SBRA leads in 4 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Welltower Inc. is the stronger pick specifically for growth and revenue expansion and capital preservation and lower volatility. As sector peers, any of these can serve as alternatives in the same allocation.
SBRA
Sabra Health Care REIT, Inc.
The Real Estate Income Play
SBRA carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 0 yrs, beta -0.06, yield 5.8%
- Beta -0.06, yield 5.8%, current ratio 0.56x
- Lower P/E (29.5x vs 78.9x)
Best for: income & stability and defensive
WELL
Welltower Inc.
The Real Estate Income Play
WELL is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 35.8%, EPS growth -11.5%, 3Y rev CAGR 22.7%
- 230.2% 10Y total return vs SBRA's 54.1%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
Best for: growth exposure and long-term compounding
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | WELL | 35.8% FFO/revenue growth vs SBRA's 10.2% |
| Value | SBRA | Lower P/E (29.5x vs 78.9x) |
| Quality / Margins | SBRA | 19.2% margin vs WELL's 12.3% |
| Stability / Safety | WELL | Lower D/E ratio (49.5% vs 90.3%) |
| Dividends | SBRA | 5.8% yield, vs WELL's 1.3% |
| Momentum (1Y) | WELL | +43.9% vs SBRA's +24.9% |
| Efficiency (ROA) | SBRA | 2.8% ROA vs WELL's 2.3%, ROIC 3.8% vs 0.5% |
SBRA vs WELL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
FY 2025
SBRA vs WELL — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLSBRALAGGINGWELL
WELLWelltower Inc.
1leads
SBRASabra Health Care REI…
3leads
6 Total Categories
CATEGORYLEADERvs WELLMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
SBRA4/6
Valuation MetricsMultiples, price ratios, and targets
SBRA6/6
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
SBRA7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
WELL6/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
Tied
—
Income & Cash Flow (Last 12 Months)
SBRA leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 14.3x SBRA's $813M. SBRA is the more profitable business, keeping 19.2% of every revenue dollar as net income compared to WELL's 12.3%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| RevenueTrailing 12 months | $813M | $11.6B |
| EBITDAEarnings before interest/tax | $432M | $2.8B |
| Net IncomeAfter-tax profit | $156M | $1.4B |
| Free Cash FlowCash after capex | $367M | $2.5B |
| Gross MarginGross profit ÷ Revenue | +63.5% | +39.1% |
| Operating MarginEBIT ÷ Revenue | +29.0% | +4.4% |
| Net MarginNet income ÷ Revenue | +19.2% | +12.3% |
| FCF MarginFCF ÷ Revenue | +45.1% | +21.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +20.8% | +40.3% |
| EPS Growth (YoY)Latest quarter vs prior year | -5.9% | +22.5% |
SBRA leads this category, winning 4 of 6 comparable metrics.
Valuation Metrics
SBRA leads this category, winning 6 of 6 comparable metrics.
Valuation Metrics
At 31.8x trailing earnings, SBRA trades at a 79% valuation discount to WELL's 154.2x P/E. On an enterprise value basis, SBRA's 16.9x EV/EBITDA is more attractive than WELL's 66.8x.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| Market CapShares × price | $5.1B | $150.1B |
| Enterprise ValueMkt cap + debt − cash | $7.6B | $166.5B |
| Trailing P/EPrice ÷ TTM EPS | 31.84x | 154.17x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.54x | 78.89x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 16.90x | 66.76x |
| Price / SalesMarket cap ÷ Revenue | 6.63x | 14.08x |
| Price / BookPrice ÷ Book value/share | 1.76x | 3.37x |
| Price / FCFMarket cap ÷ FCF | 14.74x | 52.72x |
SBRA leads this category, winning 6 of 6 comparable metrics.
Profitability & Efficiency
SBRA leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
SBRA delivers a 5.6% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $3 for WELL. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to SBRA's 0.90x. On the Piotroski fundamental quality scale (0–9), WELL scores 7/9 vs SBRA's 5/9, reflecting strong financial health.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| ROE (TTM)Return on equity | +5.6% | +3.5% |
| ROA (TTM)Return on assets | +2.8% | +2.3% |
| ROICReturn on invested capital | +3.8% | +0.5% |
| ROCEReturn on capital employed | +5.2% | +0.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.90x | 0.49x |
| Net DebtTotal debt minus cash | $2.5B | $16.3B |
| Cash & Equiv.Liquid assets | $72M | $5.0B |
| Total DebtShort + long-term debt | $2.6B | $21.4B |
| Interest CoverageEBIT ÷ Interest expense | 2.40x | 0.26x |
SBRA leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $31,264 today (with dividends reinvested), compared to $15,337 for SBRA. Over the past 12 months, WELL leads with a +43.9% total return vs SBRA's +24.9%. The 3-year compound annual growth rate (CAGR) favors WELL at 41.3% vs SBRA's 28.5% — a key indicator of consistent wealth creation.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| YTD ReturnYear-to-date | +8.0% | +15.0% |
| 1-Year ReturnPast 12 months | +24.9% | +43.9% |
| 3-Year ReturnCumulative with dividends | +112.4% | +182.2% |
| 5-Year ReturnCumulative with dividends | +53.4% | +212.6% |
| 10-Year ReturnCumulative with dividends | +54.1% | +230.2% |
| CAGR (3Y)Annualised 3-year return | +28.5% | +41.3% |
WELL leads this category, winning 6 of 6 comparable metrics.
Risk & Volatility
Evenly matched — SBRA and WELL each lead in 1 of 2 comparable metrics.
Risk & Volatility
SBRA is the less volatile stock with a -0.06 beta — it tends to amplify market swings less than WELL's 0.13 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.06x | 0.13x |
| 52-Week HighHighest price in past year | $21.07 | $219.59 |
| 52-Week LowLowest price in past year | $17.04 | $142.65 |
| % of 52W HighCurrent price vs 52-week peak | +96.7% | +97.6% |
| RSI (14)Momentum oscillator 0–100 | 54.0 | 62.6 |
| Avg Volume (50D)Average daily shares traded | 2.1M | 2.6M |
Evenly matched — SBRA and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Evenly matched — SBRA and WELL each lead in 1 of 2 comparable metrics.
Analyst Outlook
Wall Street rates SBRA as "Hold" and WELL as "Buy". Consensus price targets imply 5.7% upside for WELL (target: $227) vs 4.0% for SBRA (target: $21). For income investors, SBRA offers the higher dividend yield at 5.81% vs WELL's 1.29%.
| Metric | SBRASabra Health Care… | WELLWelltower Inc. |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $21.20 | $226.50 |
| # AnalystsCovering analysts | 29 | 34 |
| Dividend YieldAnnual dividend ÷ price | +5.8% | +1.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 |
| Dividend / ShareAnnual DPS | $1.18 | $2.76 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% |
Evenly matched — SBRA and WELL each lead in 1 of 2 comparable metrics.
Key Takeaway
SBRA leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). WELL leads in 1 (Total Returns). 2 tied.
Best OverallSabra Health Care REIT, Inc. (SBRA)Leads 3 of 6 categories
Loading custom metrics...
SBRA vs WELL: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is SBRA or WELL a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). Sabra Health Care REIT, Inc. (SBRA) offers the better valuation at 31. 8x trailing P/E (29. 5x forward), making it the more compelling value choice. Analysts rate Welltower Inc. (WELL) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBRA or WELL?
On trailing P/E, Sabra Health Care REIT, Inc.
(SBRA) is the cheapest at 31. 8x versus Welltower Inc. at 154. 2x. On forward P/E, Sabra Health Care REIT, Inc. is actually cheaper at 29. 5x.
03Which is the better long-term investment — SBRA or WELL?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +212. 6%, compared to +53. 4% for Sabra Health Care REIT, Inc. (SBRA). Over 10 years, the gap is even starker: WELL returned +230. 2% versus SBRA's +54. 1%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBRA or WELL?
By beta (market sensitivity over 5 years), Sabra Health Care REIT, Inc.
(SBRA) is the lower-risk stock at -0. 06β versus Welltower Inc. 's 0. 13β — meaning WELL is approximately -305% more volatile than SBRA relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 90% for Sabra Health Care REIT, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — SBRA or WELL?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus 10. 2% for Sabra Health Care REIT, Inc. (SBRA). On earnings-per-share growth, the picture is similar: Sabra Health Care REIT, Inc. grew EPS 18. 5% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBRA or WELL?
Sabra Health Care REIT, Inc.
(SBRA) is the more profitable company, earning 20. 1% net margin versus 8. 8% for Welltower Inc. — meaning it keeps 20. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SBRA leads at 34. 1% versus 3. 3% for WELL. At the gross margin level — before operating expenses — SBRA leads at 65. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBRA or WELL more undervalued right now?
On forward earnings alone, Sabra Health Care REIT, Inc.
(SBRA) trades at 29. 5x forward P/E versus 78. 9x for Welltower Inc. — 49. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for WELL: 5. 7% to $226. 50.
08Which pays a better dividend — SBRA or WELL?
All stocks in this comparison pay dividends.
Sabra Health Care REIT, Inc. (SBRA) offers the highest yield at 5. 8%, versus 1. 3% for Welltower Inc. (WELL).
09Is SBRA or WELL better for a retirement portfolio?
For long-horizon retirement investors, Sabra Health Care REIT, Inc.
(SBRA) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 06), 5. 8% yield). Both have compounded well over 10 years (SBRA: +54. 1%, WELL: +230. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBRA and WELL?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SBRA is a small-cap income-oriented stock; WELL is a mid-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(SBRA: 20.8% · WELL: 40.3%)Net Margin>
%
(SBRA: 19.2% · WELL: 12.3%)P/E Ratio<
x
(SBRA: 31.8x · WELL: 154.2x)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.